Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis

By using a carcinogen-injected dietary obesity model, we demonstrated that eicosapentaenoic acid attenuated the development of hepatocellular carcinoma associated with obesity by inhibiting the activation of STAT3 and subsequent tumor cell proliferation without affecting hepatic inflammation.

• Publication year

  2017

• Venue

  Carcinogenesis

• Publication date

  2017-10-12

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1093/carcin/bgx112PMID 29040439PMCID 5862334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment

  2016cited by this paper
• Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice

  2016cited by this paper
• Body Fatness and Cancer--Viewpoint of the IARC Working Group.

  2016cited by this paper
• Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.

  2016cited by this paper
• Different Associations of CD45 Isoforms with STAT3, PKC and ERK Regulate IL-6-Induced Proliferation in Myeloma

  2015cited by this paper
• Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.

  2015cited by this paper
• Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.

  2015cited by this paper
• Eicosapentaenoic Acid Ameliorates Non-Alcoholic Steatohepatitis in a Novel Mouse Model Using Melanocortin 4 Receptor-Deficient Mice

  2015cited by this paper
• Adiposity and cancer risk: new mechanistic insights from epidemiology

  2015cited by this paper
• Obesity and cancer—mechanisms underlying tumour progression and recurrence

  2014cited by this paper
• NAFLD, NASH and liver cancer

  2013cited by this paper
• Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?

  2013cited by this paper
• Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.

  2013cited by this paper
• Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells

  2013cited by this paper
• Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

  2012cited by this paper
• Mechanisms of action of (n-3) fatty acids.

  2012influential reference
• Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.

  2011cited by this paper
• Animal models of nonalcoholic fatty liver disease

  2011cited by this paper
• Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages.

  2010cited by this paper
• Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.

  2010influential reference
• Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice.

  2009cited by this paper
• Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2

  2009cited by this paper
• The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.

  2008cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates

  2006cited by this paper
• Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

  2005cited by this paper
• Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

  2004cited by this paper
• Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

  2004cited by this paper
• (n-3) fatty acids and cancer therapy.

  2004cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• Obesity and hepatocellular carcinoma.

  2004cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• Lipid rafts Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.R200021-JLR200

  2003cited by this paper
• IL-6 signal transduction and its physiological roles: the signal orchestration model.

  2003cited by this paper
• STAT proteins: novel molecular targets for cancer drug discovery

  2000cited by this paper
• International Agency for Research on Cancer.

  1968cited by this paper

• Polyunsaturated fatty acids as a potential preventive and therapeutic intervention for metabolic dysfunction-associated steatotic liver disease and its progression to hepatocellular carcinoma.

  2026cites this paper
• Causal associations between dietary habits and liver cancer risk: a two-sample Mendelian randomization study

  2025cites this paper
• Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma

  2024cites this paper
• Lipidomics Investigation Reveals the Reversibility of Hepatic Injury by Silica Nanoparticles in Rats After a 6‐Week Recovery Duration

  2024cites this paper
• Protective effect of eicosapentaenoic acid against estradiol valerate-induced endometrial hyperplasia via modulation of NF-κB/HIF-1α/VEGF signaling pathway in rats.

  2023cites this paper
• Fatty acid profile, total phenolic content and antioxidant capacity of seaweeds in Salinas Bay, Ecuador

  2023cites this paper
• Protective effect of Salvia hispanica (chia seeds) against obesity induced ovarian disorders in rat model.

  2023cites this paper
• Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma

  2023cites this paper
• Eicosapentaenoic acid loaded silica nanoemulsion attenuates hepatic inflammation through the enhancement of cell membrane components

  2022cites this paper
• Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics

  2021cites this paper
• Influence of omega-3 fatty acids and monounsaturated fats in liver diseases

  2021cites this paper
• LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis

  2021cites this paper
• A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis

  2021cites this paper
• Eicosapentaenoic Acid Inhibits KRAS Mutant Pancreatic Cancer Cell Growth by Suppressing Hepassocin Expression and STAT3 Phosphorylation

  2021cites this paper
• Perioperative omega-3 fatty acids for liver surgery

  2021cites this paper
• DHA/EPA supplementation decreases anxiety-like behaviour, but it does not ameliorate metabolic profile in obese male rats

  2021cites this paper
• Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options

  2021cites this paper
• Relationship Between Fish Oil Use and Incidence of Primary Liver Cancer: Findings From a Population-Based Prospective Cohort Study

  2021cites this paper
• A meta-analysis of randomized controlled trials

  2021cites this paper
• Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma

  2020cites this paper
• Physico-chemical characterisation of Capparis scabrida seed oil and pulp, a potential source of eicosapentaenoic acid

  2020cites this paper
• Carcinogenesis: Failure of resolution of inflammation?

  2020cites this paper
• High-fat diet-induced dysregulation of ovarian gene expression is restored with chronic Omega-3 fatty acid supplementation.

  2020cites this paper
• Perioperative Omega-3 fatty Acids Fails to Confer Protection in Liver Surgery. Results of a multicentric, double-blind, randomized controlled trial.

  2020cites this paper
• Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma

  2020cites this paper
• Chlorpyrifos-induced dysfunction of lipid metabolism is not restored by supplementation of polyunsaturated fatty acids EPA and ARA in Atlantic salmon liver cells.

  2019cites this paper
• Fat-1 Transgene Is Associated With Improved Reproductive Outcomes.

  2018cites this paper
• Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

  2018cites this paper
• Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus

  2018cites this paper